Senior insider sale
CMO, SVP & Head of Drug Devt. at IRONWOOD PHARMACEUTICALS INC — senior position signals high conviction
$138.0K
29.94K shares
SHETZLINE MICHAEL plans to sell 29.94K shares of IRONWOOD PHARMACEUTICALS INC valued at approximately $138.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
N/A
Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements
Nasdaq
Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
Nasdaq
Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements
N/A
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2025 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements N/A | 33.33K | — |
2/12/2024 | Restricted Stock Unit award granted pursuant to the Issuer's Amended and Restated 2019 Equity Incentive Plan, subject to vesting requirements Nasdaq | 13.61K | — |
3/8/2023 | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements Nasdaq | 17.47K | — |
3/2/2022 | Restricted Stock Unit award granted pursuant to the Issuer's 2019 Equity Incentive Plan, subject to vesting requirements N/A | 20.36K | — |
| Total | 84.77K | ||
Units to sell
29.94K
Market value
$138.0K
Units
29.94K
Value
$138.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/23/2026 | 29.94K | $138.0K | Nasdaq | Planned |
| Total | 29.94K | $138.0K | ||